Segment information (Tables)

12 Months Ended

Jun. 30, 2012

Financial Information Relating to Operating Segments

Following is financial information relating to the operating segments (in thousands):


	Year Ended June 30,
	2012			2011			2010
External sales
Biotechnology	$	293,274		$	270,287		$	250,653
Hematology		21,286			19,675			18,394

Consolidated net sales	$	314,560		$	289,962		$	269,047

Earnings before taxes
Biotechnology	$	162,763		$	164,332		$	155,989
Hematology		8,002			7,222			6,869

Segment earnings before taxes		170,765			171,554			162,858
Other		(8,570	)		(6,573	)		(6,412	)

Consolidated earnings before taxes	$	162,195		$	164,981		$	156,446

Goodwill
Biotechnology	$	85,682		$	86,633		$	25,068
Hematology		0			0			0

Consolidated goodwill	$	85,682		$	86,633		$	25,068

Intangible assets, net
Biotechnology	$	46,476		$	52,282		$	2,044
Hematology		0			0			0

Consolidated intangible assets, net	$	46,476		$	52,282		$	2,044

Assets
Biotechnology	$	529,392		$	505,087		$	400,112
Hematology		22,135			21,046			18,543

Segment assets		551,527			526,133			418,655
Other		167,797			91,537			100,161

Consolidated assets	$	719,324		$	617,670		$	518,816

Depreciation and amortization
Biotechnology	$	10,920		$	7,165		$	5,411
Hematology		411			417			340

Segment depreciation and amortization		11,331			7,582			5,751
Other		1,136			1,118			2,379

Consolidated depreciation and amortization	$	12,467		$	8,700		$	8,130

Capital purchases
Biotechnology	$	4,021		$	2,707		$	3,885
Hematology		597			149			208

Segment capital purchases		4,618			2,856			4,093
Other		1,399			774			551

Consolidated capital purchases	$	6,017		$	3,630		$	4,644

Financial Information Relating to Geographic Areas

Following is financial information relating to geographic areas (in thousands):


	Year Ended June 30,
	2012		2011		2010
External sales
United States	$	172,310	$	159,857	$	148,137
Europe		90,142		83,676		78,496
China		11,378		8,299		6,792
Other Asia		25,988		24,715		22,372
Rest of world		14,742		13,415		13,250

Total external sales	$	314,560	$	289,962	$	269,047

Long-lived assets
United States	$	87,968	$	88,802	$	91,554
Europe		7,528		7,819		6,299
China		141		96		70

Total long-lived assets	$	95,637	$	96,717	$	97,923

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References+ Details

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details